-+ 0.00%
-+ 0.00%
-+ 0.00%

Caris Life Sciences Announces Dual Listing Of Common Shares On NYSE Texas, Effective June 17

Benzinga·06/16/2026 12:32:28
Listen to the news

Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the dual listing of its common stock on NYSE Texas effective on June 17, 2026, further expanding its presence in the public markets.